A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

April 18, 2024

Study Completion Date

December 23, 2024

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Elezanumab

Intravenous (IV) infusion

DRUG

Placebo

Intravenous (IV) infusion

Trial Locations (42)

2065

Royal North Shore Hospital /ID# 239083, St Leonards

3050

The Royal Melbourne Hospital /ID# 240178, Parkville

13496

Duplicate_CHA University Bundang Medical Center /ID# 233503, Seongnam-si

15006

Complejo Hospitalario Universitario A Coruña /ID# 230080, A Coruña

18103

Lehigh Valley Health Network /ID# 242446, Allentown

19107

Thomas Jefferson University Hospital /ID# 215469, Philadelphia

20007

Georgetown University Hospital /ID# 216481, Washington D.C.

20014

Hospital Donostia /ID# 218034, Donostia / San Sebastian

22908

University of Virginia /ID# 215757, Charlottesville

28046

Hospital Universitario La Paz /ID# 216380, Madrid

32224

Mayo Clinic /ID# 217567, Jacksonville

40202

University of Louisville Hospital /ID# 217569, Louisville

40536

Duplicate_University of Kentucky Chandler Medical Center /ID# 216394, Lexington

41009

Hospital Universitario Virgen Macarena /ID# 216382, Seville

41013

Hospital Universitario Virgen del Rocio /ID# 216339, Seville

43210

The Ohio State University /ID# 215036, Columbus

44106

UH Cleveland Medical Center /ID# 215372, Cleveland

44195

Cleveland Clinic Main Campus /ID# 214635, Cleveland

48903

OSI Ezkerraldea-Enkarterri-Cruces /ID# 217529, Barakaldo

49241

Duplicate_Pusan National University Hospital /ID# 233769, Busan

63110

Washington University-School of Medicine /ID# 214526, St Louis

85054

Mayo Clinic Arizona /ID# 214957, Phoenix

3818551

Nagano Municipal Hospital /ID# 240622, Nagano

90808-1731

Long Beach Medical Center /ID# 217210, Long Beach

60611-2927

Northwestern University Feinberg School of Medicine /ID# 215047, Chicago

02111-1552

Tufts Medical Center /ID# 215053, Boston

39216-4500

University of Mississippi Medical Center /ID# 217587, Jackson

64111-3220

St. Luke's Marion Bloch Neuroscience Institute /ID# 215028, Kansas City

07601

Hackensack Univ Med Ctr /ID# 218200, Hackensack

87131-0001

University of New Mexico School of Medicine /ID# 216827, Albuquerque

10032-3729

Columbia University Medical Center /ID# 215122, New York

77030-1501

University of Texas Health Science Center at Houston /ID# 215018, Houston

76508-0001

Baylor Scott & White Medical Center- Temple /ID# 225513, Temple

T6G 2B7

University of Alberta Hospital /ID# 218370, Edmonton

L8L 2X2

Hamilton General Hospital /ID# 218970, Hamilton

818-8502

Fukuoka University Chikushi Hospital /ID# 240629, Chikushino-shi

811-0213

Fukuoka Wajiro Hospital /ID# 239810, Fukuoka

892-0853

National Hospital Organization Kagoshima Medical Center /ID# 240021, Kagoshima

747-8511

Yamaguchi Grand Medical Center /ID# 239892, Hohu-shi

03080

Seoul National University Hospital /ID# 233473, Seoul

06351

Samsung Medical Center /ID# 234241, Seoul

08035

Hospital Universitario Vall d'Hebron /ID# 217087, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY